Stratifying Alzheimer’s disease by patient-specific genetic signatures reveals cognition-linked and cross-disease heterogeneity
Alzheimer’s disease (AD) presents profound clinical and genetic heterogeneity that obscures its biological underpinnings and impedes therapeutic development. While genome-wide studies have identified population-level risk loci, the architecture of patient-specific genetic variation and its link to clinical outcomes rem...